

Type 1 Diabetes Autoimmune Panel
Become a member to unlock discounted pricing and exclusive perks.
Diabetes autoantibodies assessment is helpful in identifying and managing patients at risk for development of type 1 diabetes. Published positivity rates for diabetes autoantibodies in new-onset type 1 diabetes patients listed below are based on the combined analysis of GAD-65, ICA 512, insulin antibodies, and ZnT8 antibodies. The combined analysis has a 98% autoimmunity detection rate, with 1.8% diabetic individuals remaining as autoantibody-negative. Fewer than 3% of type 2 diabetics have positive antibodies. Positive rate in new-onset type 1 diabetes patients: GAD-65 antibodies = 68% positive, ICA 512 antibodies = 72% positive, Insulin antibodies = 55% positive, ZnT8 antibodies = 63% positive. An increase in the number of positive antibodies is associated with a higher likelihood of type 1 diabetes.
Quick facts
Serum, frozen
2–4 business days
No Fasting Required
Licensed physician review and requisition included with every test.

How It Works?

once Test Order is received, Our physicians will review your request and email you the easy-to-follow requisition form.

Find the closest partner location—most are within 2–3 miles—and drop by for a quick, no‑appointment blood draw.

Once your sample is processed, we’ll send your report straight to your inbox within 1–3 business days. Just click the link to view your results anytime.

Have Questions about results? Book a phone or video visit with one of our doctors. They’ll walk you through your report, explain any findings, and recommend next steps